Approvals/TGA/HALAVEN eribulin mesilate 1 mg/2 mL solution for injection glass vial

Approved

STANDARD

HALAVEN eribulin mesilate 1 mg/2 mL solution for injection glass vial

Eisai Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 1adf6ead1679e9be
Product Name: HALAVEN eribulin mesilate 1 mg/2 mL solution for injection glass vial
Artg Id: 187136
Artg Name: HALAVEN eribulin mesilate 1 mg/2 mL solution for injection glass vial
Sponsor: Eisai Australia Pty Ltd
Company Detail Path: /organization/eisai-australia-pty-ltd
Artg Date: 2012-09-04
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/d4478ad23321708204fb699d0597b769.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/1088876fa07b255878441e172cecc651.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

1adf6ead1679e9be

Type

Standard